ALEMTUZUMAB

19365 reported adverse events

Drug classes: CD52-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking ALEMTUZUMAB:

# Side effect Count
0 HEADACHE 1906
1 FATIGUE 1874
2 PYREXIA 1784
3 OFF LABEL USE 1698
4 RASH 1200
5 NAUSEA 1190
6 DRUG INEFFECTIVE 1032
7 DYSPNOEA 985
8 ASTHENIA 942
9 MULTIPLE SCLEROSIS RELAPSE 923
See all common reactions for ALEMTUZUMAB

ALEMTUZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACTINOMYCOTIC SEPSIS 18 0.7200
1 THYROID STIMULATING IMMUNOGLOBULIN 18 0.5806
2 SPECIFIC GRAVITY URINE DECREASED 71 0.4610
3 HAEMOGLOBIN URINE PRESENT 80 0.3941
4 URINE LEUKOCYTE ESTERASE 22 0.3729
5 BACTERIAL TEST 111 0.3725
6 T-CELL PROLYMPHOCYTIC LEUKAEMIA 34 0.3656
7 CRYSTAL URINE PRESENT 187 0.3363
8 SPECIFIC GRAVITY URINE INCREASED 44 0.3284
9 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 19 0.3220
See all enriched reactions for ALEMTUZUMAB